The North America Intermittent Catheter Market would witness market growth of 4.0% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 2,24,851.0 thousand units, showcasing a growth of 4.2% (2019-2022).
One of the prominent trends shaping the market is the heightened focus on infection prevention. Catheter-associated urinary tract infections (CAUTIs) are a significant concern, prompting manufacturers and healthcare providers to invest in catheter designs incorporating antimicrobial coatings and materials. This trend addresses the critical issue of patient safety and aligns with broader healthcare goals of reducing healthcare-associated infections.
Moreover, the market is witnessing a shift towards customization and patient-centric solutions. Recognizing the diverse needs of individuals with urinary disorders, manufacturers offer a spectrum of sizes, lengths, and types of intermittent catheters. This trend empowers healthcare providers to tailor catheter solutions to the specific requirements of each patient, fostering improved comfort, compliance, and efficacy. The trend towards customization enables healthcare providers to tailor catheter solutions to the specific requirements of each patient. Whether addressing variations in anatomy, accommodating different levels of mobility, or considering individual preferences, the availability of diverse catheter options ensures that patients receive a solution that aligns with their unique needs.
Prostate cancer is one of the most common cancers among Canadian men. The aging population and improved cancer detection methods contribute to an increasing incidence of prostate cancer. As the number of prostate cancer cases rises, the demand for interventions to manage associated symptoms, such as urinary retention, is likely to grow. As per the data provided by the Government of Canada, prostate cancer is the 4th most common cancer in Canada. A lifetime prostate cancer diagnosis is anticipated for 1 in 9 males. About 23,300 men were expected to be diagnosed with prostate cancer in 2020. Thus, rising urinary incontinence and prostate cancer cases in North America will boost the demand for intermittent catheters in the region.
The US market dominated the North America Intermittent Catheter Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $664.9 million by 2030. The Canada market is exhibiting a CAGR of 6% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 5.4% during (2023 - 2030).
Based on Product, the market is segmented into Uncoated, and Coated. Based on Coated Type, the market is segmented into Hydrophilic, Antimicrobial, and Others. Based on Indication, the market is segmented into Urinary Incontinence, Spinal Cord Injuries, General Surgery, and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Medical Research Centers. Based on Category, the market is segmented into Female Length Catheter, Male Length Catheter, and Kid Length Catheter. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
One of the prominent trends shaping the market is the heightened focus on infection prevention. Catheter-associated urinary tract infections (CAUTIs) are a significant concern, prompting manufacturers and healthcare providers to invest in catheter designs incorporating antimicrobial coatings and materials. This trend addresses the critical issue of patient safety and aligns with broader healthcare goals of reducing healthcare-associated infections.
Moreover, the market is witnessing a shift towards customization and patient-centric solutions. Recognizing the diverse needs of individuals with urinary disorders, manufacturers offer a spectrum of sizes, lengths, and types of intermittent catheters. This trend empowers healthcare providers to tailor catheter solutions to the specific requirements of each patient, fostering improved comfort, compliance, and efficacy. The trend towards customization enables healthcare providers to tailor catheter solutions to the specific requirements of each patient. Whether addressing variations in anatomy, accommodating different levels of mobility, or considering individual preferences, the availability of diverse catheter options ensures that patients receive a solution that aligns with their unique needs.
Prostate cancer is one of the most common cancers among Canadian men. The aging population and improved cancer detection methods contribute to an increasing incidence of prostate cancer. As the number of prostate cancer cases rises, the demand for interventions to manage associated symptoms, such as urinary retention, is likely to grow. As per the data provided by the Government of Canada, prostate cancer is the 4th most common cancer in Canada. A lifetime prostate cancer diagnosis is anticipated for 1 in 9 males. About 23,300 men were expected to be diagnosed with prostate cancer in 2020. Thus, rising urinary incontinence and prostate cancer cases in North America will boost the demand for intermittent catheters in the region.
The US market dominated the North America Intermittent Catheter Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $664.9 million by 2030. The Canada market is exhibiting a CAGR of 6% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 5.4% during (2023 - 2030).
Based on Product, the market is segmented into Uncoated, and Coated. Based on Coated Type, the market is segmented into Hydrophilic, Antimicrobial, and Others. Based on Indication, the market is segmented into Urinary Incontinence, Spinal Cord Injuries, General Surgery, and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Medical Research Centers. Based on Category, the market is segmented into Female Length Catheter, Male Length Catheter, and Kid Length Catheter. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Becton Dickinson and Company
- B.Braun Melsungen AG
- Coloplast Group
- Hollister, Inc.
- Teleflex Incorporated
- ConvaTec Group PLC
- Cook Medical, Inc. (Cook Group)
- Wellspect Healthcare AB
- Adapta Medical, Inc.
- Pennine Healthcare
Market Report Segmentation
By Product (Volume, Thousand Units, USD Billion, 2019-2030)- Uncoated
- Coated
- Hydrophilic
- Antimicrobial
- Others
- Urinary Incontinence
- Spinal Cord Injuries
- General Surgery
- Others
- Hospitals
- Ambulatory Surgical Centers
- Medical Research Centers
- Female Length Catheter
- Male Length Catheter
- Kid Length Catheter
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Intermittent Catheter Market by Product
Chapter 5. North America Intermittent Catheter Market by Indication
Chapter 6. North America Intermittent Catheter Market by End User
Chapter 7. North America Intermittent Catheter Market by Category
Chapter 8. North America Intermittent Catheter Market by Country
Chapter 9. Company Profiles
Samples
LOADING...
Companies Mentioned
- Becton Dickinson and Company
- B. Braun Melsungen AG
- Coloplast Group
- Hollister, Inc.
- Teleflex Incorporated
- ConvaTec Group PLC
- Cook Medical, Inc. (Cook Group)
- Wellspect Healthcare AB
- Adapta Medical, Inc.
- Pennine Healthcare
Methodology
LOADING...
